Skip to main content
. 2023 Apr 11;8(7):1323–1331. doi: 10.1016/j.ekir.2023.04.005

Table 2.

Primary and secondary outcomes

Outcomes Dialysate K 2 mmol/l (total = 695 sessions) Dialysate K 3 mmol/l (total = 685 sessions) P
Primary outcome
Proportion of dialysis session with intradialytic hypertensiona 380 (54.7) 364 (53.1) 0.788b
Secondary outcome
Proportion of dialysis session with that had intradialytic systolic blood pressure increased >20 mm Hg 231 (33.2) 217 (31.7) 0.932b
Average intradialytic systolic blood pressure (mm Hg) 140.7 ± 12.2 143.7 ± 13.4 Treatment effect: P = 0.001
Sequence effect: P = 0.458
Period effect:
P = 0.445
Carryover effect: P = 0.058
Average intradialytic mean arterial pressure (mm Hg) 99.0 ± 11.4 100.9 ± 11.8 Treatment effect: P = 0.011
Sequence effect: P = 0.236
Period effect:
P = 0.557
Carryover effect: P = 0.044
a

Intradialytic hypertension was defined as an increase in intradialytic systolic blood pressure of more than 10 mm Hg. Data were presented in mean ± SD or n (%).

b

P values were calculated by mixed-effects logistic regression.